Joslin Mevanismo Center and Joslin Clinic. Clinical pharmacokinetics of metformin. A prospective randomized study. Targets and Therapy Consumo de agua en el embarazo y lactancia. The mechanisms of action of PPARs. Pak J Med Sci ; Evidence-based risk assessment and recommendations for physical activity clearance: Cell Metab ; 3: Frequency and outcome of treatment in polycystic ovaries related infertility.
Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome. Systematic review and meta-analysis. Estudios de prevalencia en Venezuela: The last ten years. Practice Bulletin No Recognize and treat any degree of impaired glucose affecting pregnancy leads to decreased maternal and fetal, immediate and bighanidas complications. No es recomendable administrar cantidades elevadas o bolos de glucosa, por el peligro de hipoxia fetal, acidosis fetal o neonatal e hipoglucemia neonatal.
N Engl J Med ; Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
Arch Intern Med ; Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: A systematic review and meta-analysis. Ann Intern Med ; Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis.
Oncologist ; Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia ; The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Science ; Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review. Effectiveness and safety of metformin in 51 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open ; 2:e Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Association of metformin use with risk of lactic acidosis across the range of kidney function: A community-based cohort study. J Clin Endocrinol Metab ; [Pubmed]. Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA randomized clinical trial. JAMA ; Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials. Diabetes Obes Metab ; The association between sulfonylurea use and all-cause and cardiovascular mortality: A meta-analysis with trial sequential analysis of randomized clinical trials.
PLoS Med ; e The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis.
Diabetes Metab Res Rev ; Meglitinide analogues for type 2 diabetes mellitus. Hauner H. The mode of action of thiazolidinediones. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes RECORD : a multicentre, randomised, open-label trial. Factores adicionales a tener en cuenta. Es frecuente el dolor abdominal, meteorismo y diarrea, pero su incidencia disminuye si se empieza con dosis bajas, y se aumenta de forma paulatina y se sigue estrictamente la dieta recomendada.
Presentan bajo riesgo de producir hipoglucemia. Algunos fracasos. En caso de olvido de dosis, se recomienda actuar de la siguiente manera:. Los problemas de hipoglucemia limitan en algunos casos su empleo, sobre todo aquellas sulfonilureas con semivida larga. Figura 1. Bot Plus 2. Panorama Actual del Medicamento ; Diabetes Care ; Engl J Med ; English P, Williams G. Hyperglycaemic crises and lactic aci- Morbidity dosis in diabetes mellitus. Postgrad Med J ; Initial management of glycemia in type 2 diabetes teen year follow-up study.
Diabetes ; Panzram G. Mortality and survival in type 2 non-insulin-de- Nattrass M, Alberti KG. Diabetologia ; pendent diabetes mellitus. Gerich JE. Oral hypoglycemic agents. N Engl J Med Effect of intensive treatment of diabetes on the development ; Bailey CJ, Nattrass M. Baillieres Clin dent diabetes mellitus. N Engl J Med ; Endocrinol Metab ; Double-blind Therapeutic comparison of metformin and sulfonylurea, alone evaluation of efficacy and tolerability of metformin in NIDDM.
Asmal AC, Marble A. Oral hypoglycaemic agents. An update. Prospective Diabetes Study Group. Prospective Stu- Drugs ; Diabetes Wilcock C, Bailey CJ. Reconsideration of inhibitory effect of ; J Pharm Pharma- Prospective col ; Sites of metformin-stimulated glucose cated diet, sulphonylurea, insulin, or metformin in patients with metabolism.
Biochem Pharmacol ; Mechanism of three years. BMJ ; Bailey CJ, Day C. Traditional plant medicines as treatments ; Diabetes Care ; Mechanism of met- Sterne J. Pharmacology and mode of action of hypoglycaemic formin action in obese and lean noninsulin-dependent diabetic guanidine derivates. In: Campbell GD, ed. Oral Hypoglycaemic subjects. J Clin Endocrinol Metab ; London-New York: Academic Press,pp Fantus IG, Brosseau R. Mechanism of action of metformin: Beckmann R.
Biguanide Experimental Teil. In: Maske H, ed. Oral Insulin receptor and postreceptor effects in vitro and in vivo. Wirksame Antidiabetika. Berlin: Springer-Verlag,pp Wollen N, Bailey CJ. Metformin potentiates the antigluconeo- Hermann LS, Melander A. Biguanides: basic aspects and genic action of insulin.
Inhibition of hepatic gluconeogenesis by met P, eds. International textbook of diabetes mellitus. Vol 1. Biochem Pharmacol ; Chichester: John Wiley, pp Metformin-an update. Gen Pharmacol ; Direct Metabolism Combined metformin-sulfonylurea treatment of patients
0コメント